- Home
- CHPT vs VALN Comparison
CHPT vs VALN Comparison
Compare CHPT & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- VALN
- Stock Information
- Founded
- CHPT 2007
- VALN 2012
- Country
- CHPT United States
- VALN France
- Employees
- CHPT N/A
- VALN N/A
- Industry
- CHPT Industrial Specialties
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHPT Consumer Discretionary
- VALN Health Care
- Exchange
- CHPT Nasdaq
- VALN Nasdaq
- Market Cap
- CHPT 321.7M
- VALN 510.7M
- IPO Year
- CHPT N/A
- VALN 2021
- Fundamental
- Price
- CHPT $0.70
- VALN $6.40
- Analyst Decision
- CHPT Hold
- VALN Strong Buy
- Analyst Count
- CHPT 10
- VALN 3
- Target Price
- CHPT $1.58
- VALN $15.33
- AVG Volume (30 Days)
- CHPT 10.5M
- VALN 83.3K
- Earning Date
- CHPT 06-04-2025
- VALN 05-07-2025
- Dividend Yield
- CHPT N/A
- VALN N/A
- EPS Growth
- CHPT N/A
- VALN N/A
- EPS
- CHPT N/A
- VALN N/A
- Revenue
- CHPT $417,083,000.00
- VALN $201,099,222.00
- Revenue This Year
- CHPT $12.03
- VALN $18.74
- Revenue Next Year
- CHPT $26.85
- VALN $29.26
- P/E Ratio
- CHPT N/A
- VALN N/A
- Revenue Growth
- CHPT N/A
- VALN 21.64
- 52 Week Low
- CHPT $0.51
- VALN $3.62
- 52 Week High
- CHPT $2.44
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- CHPT 52.86
- VALN 48.49
- Support Level
- CHPT $0.69
- VALN $6.18
- Resistance Level
- CHPT $0.79
- VALN $6.54
- Average True Range (ATR)
- CHPT 0.05
- VALN 0.21
- MACD
- CHPT 0.00
- VALN 0.01
- Stochastic Oscillator
- CHPT 37.40
- VALN 54.35
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.